meta
|
COVID-19
Dynamic meta-analysis of evidences about drug efficacy and safety
adjuvant therapies
anti-inflammatoty and immuno-therapy
antiandrogenic
antiviral and associated therapy
control
honey
miscellaneous
acetylcysteine
alpha lipoic acid
aviptadil
bevacizumab
bismuth
BLD-2660 (calpain inhibitor)
calcium channel blocker
camostat mesilate
continuous positive airway pressure (CPAP)
cytokine adsorption
diammonium glycyrrhizinate
dipyridamol
DPP-4 inhibitor
enoxaparin
famotidine
kinin-kallikrein inhibitors
levamisole
metformin
natural killer (NK) cells
nicotin
nitric oxide (gas Inhalation or releasing solution)
ozonated autohemotherapy
pamrevlumab
povidone-iodine
proton pump inhibitors (PPI)
proxalutamide
PUL-042 inhalation solution
radiotherapy
selinexor
statins
stem cells
tradipitant
tranilast
zinc
zinc plus hydroxychloroquine
vaccines
COVID-19
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 prophylaxis
infections other than COVID-19
preventing respiratory virus transmission